Solid phase and combinatorial library syntheses of fused...

Details Solid phase and combinatorial library syntheses of fused... Solid phase and combinatorial library syntheses of fused...

1997-02-04

2002-07-02

Ponnaluri, Padmashri (Department: 1627)

Chemistry: molecular biology and microbiology

Measuring or testing process involving enzymes or...

Involving antigen-antibody binding, specific binding protein...

C436S518000, C544S285000, C544S256000, C544S279000, C544S258000, C435S091500, C435S091500, C435S091500, C435S091500

Reexamination Certificate

active

06413724

ABSTRACT:

TECHNICAL FIELD
This invention is directed to combinatorial chemistry libraries containing fused 2,4-pyrimidinediones. This invention is further directed to methods for constructing combinatorial chemistry libraries containing fused 2,4-pyrimidinediones. This invention is still further directed to methods for the identification of bioactive fused 2,4-pyrimidinediones.
BACKGROUND ART
Modem day drug discovery is a multi-faceted endeavor. Researchers commonly delineate a biochemical pathway that is operative in a targeted pathological process. This pathway is analyzed with an eye toward determining its crucial elements: those enzymes or receptors that, if modulated, could inhibit the pathological process. An assay is constructed such that the ability of the important enzyme or receptor to function can be measured. The assay is then performed in the presence of a variety of molecules. If one of the assayed molecules modulates the enzyme or receptor in a desirable fashion, this molecule may be used directly in a pharmaceutical preparation or can be chemically modified in an attempt to augment its beneficial activity. The modified molecule that exhibits the best profile of beneficial activity may ultimately be formulated as a drug for the treatment of the targeted pathological process.
With the use of high-throughput screening techniques, one can assay the activity of tens of thousands of molecules per week. Where molecules can only be synthesized one at a time, the rate of molecule submission to an assay becomes a debilitating, limiting factor. This problem has led researchers to develop methods by which large numbers of molecules possessing diverse chemical structures can be rapidly and efficiently synthesized. One such method is the construction of chemical combinatorial libraries.
Chemical combinatorial libraries are diverse collections of molecular compounds. Gordon et al. (1995)
Acc. Chem. Res.
29:144-154. These compounds are formed using a multistep synthetic route, wherein a series of different chemical modules can be inserted at any particular step in the route. By performing the synthetic route multiple times in parallel, each possible permutation of the chemical modules can be constructed. The result is the rapid synthesis of hundreds, thousands, or even millions of different structures within a chemical class.
For several reasons the initial work in combinatorial library construction focused on peptide synthesis. Furka et al. (1991)
Int. J. Peptide Protein Res.
37:487-493; Houghton et al. (1985)
Proc. Natl. Acad. Sci. USA
82:5131-5135; Geysen et al. (1984)
Proc. Natl. Acad. Sci. USA
81:3998-4002; and Fodor et al. (1991)
Science
25:767. The rapid synthesis of discrete chemical entities is enhanced where the need to purify synthetic intermediates is minimized or eliminated; synthesis on a solid support serves this function. Construction of peptides on a solid support is well-known and well-documented. Obtaining a large number of structurally diverse molecules through combinatorial synthesis is furthered where many different chemical modules are readily available; hundreds of amino acid modules are commercially available. Finally, many peptides are biologically active, making them interesting as a class to the pharmaceutical industry.
The scope of combinatorial chemistry libraries has recently been expanded beyond peptide synthesis. Polycarbamate and N-substituted glycine libraries have been synthesized in an attempt to produce libraries containing chemical entities that are similar to peptides in structure, but possess enhanced proteolytic stability, absorption and pharmacokinetic properties. Cho et al. (1993)
Science
261:1303-1305; Simon et al. (1992)
Proc. Natl. Acad. Sci. USA
89:9367-9371. Furthermore, benzodiazepine, pyrrolidine, and diketopiperazine libraries have been synthesized, expanding combinatorial chemistry to include heterocyclic entities. Bunin et al. (1992)
J. Am. Chem. Soc.
114:10997-10998; Murphy et al. (1995)
J. Am. Chem. Soc.
117:7029-7030; and Gordon et al. (1995)
Biorg. Medicinal Chem. Lett.
5:47-50.
Pyrimidinediones are a class of bioactive, heterocyclic molecules that have attracted considerable attention in the pharmaceutical industry. The benzo derivatives of this series (2,4-quinazolinediones) are represented as anti-inflammatory agents, analgesics, anticonvulsants, CNS agents, serotonin uptake inhibitors, antihypertensive agents, cardiovascular agents, and fungicides. Maillard et al. (1968)
Fr. Chim. Ther.
3:100-106; Montginoul et al. (1988)
Ann. Pharm. Franc.
46:223-232; Lowe et al. (1991)
J. Med. Chem.
34:624-628; Mignani et al. (1993)
Bioorg. Med. Chem. Lett.
3:1913-1918; Can. Pat. Appl. CA 2053475; Eur. Pat. Appl. EP 481342; and Smith et al. (1996)
Bioorg. Med. Chem. Lett.
6:1483-1486. Naturally occurring bioactive compounds, such as theophylline and theobromine, that have found application as cardiotonic agents, broncholytic agents, vasodilators, psychotonic agents, and circulation analeptic agents are heterocyclic ring fused 2-4-pyrimidinediones. Roth et al. In:
Pharmaceutical Chemistry. Volume
1:
Drug Synthesis (
1988) John Wiley & Sons. Recently, synthetic heterocyclic fused 2,4-pyrimidinediones, such as thieno and furopyrimidine-2,4-diones have been patented as serotonin antagonists and alpha adrenergic blocking agents. U.S. Pat. No. 4,835,157.
Methods for the solution phase preparation of fused 2,4-pyrimidinediones have been reported. For example, the solution phase synthesis of pyridopyrimidinediones and quinazolinediones by the reaction, respectively, of an aminonicotinic ester or anthranilate derivative with isocyanate has been described. Lowe et al. (1991)
J. Med. Chem.
34:624-628. The reaction of a carbomethoxyphenyl isocyanate with an amino acid is a further described example of solution phase chemistry used to construct fused pyrimidinediones. Canonne et al. (1993)
Heterocycles
36:1305-1314. Little work, however, has been reported on the solid phase synthesis of fused 2,4-pyrimidinediones.
An 11 step synthesis of particularly substituted 2,4-quinazolinediones using solid phase synthesis that proceeds through an anthranilate intermediate has been described. Buckman et al. (1996)
Tetrahedron Lett.
37:4439-4442. This synthetic route is inherently limited, however, to the production of phenolic 2,4-quinazolinediones due to the mode of connection between the 2,4-quinazolinedione and the solid support. Furthermore, the synthetic route is limited by the harshness of the reaction conditions employed. For instance, the cyclization of the pyrimidinedione ring requires the presence of strong potassium hydroxide: a reagent that could cause cleavage of the compound from the solid support, destroy certain functional groups such as esters, or racemize chiral groups such as amino acid derivatives. Finally, the synthetic route requires the use of air-sensitive reagents, such as lithium benzyloxazolidinone, making the automation of the synthetic protocol difficult, thus potentially reducing its application to the manual synthesis of a limited number of 2,4-quinazolinediones.
A 5 step synthesis of 2,4-quinazolinediones using solid phase synthesis that proceeds through an anthranilate intermediate has been described. Smith et al. (1996)
Biorg. & Medicinal Chem. Lett.
6:1483-1486. This route is limited in that it does not allow for the production of 2,4-quinazolinediones bound to a solid support: the last step of the synthesis both completes the pyrimidinedione ring and releases the formed compound from the solid support. The route is further limited in that it employs a moisture-sensitive chloroformate derivatized polymeric support that has to be prepared immediately before use. Finally, the final synthetic step requires a high reaction temperature virtually excluding the application of standard equipment used for the automated synthesis of combinatorial libraries. Therefore the scope of the application of this method is severely limited.
A four step synthesis of pyrido[2,3-d]pyrimidines has been

Affiliated with

Also associated with

Rating

Solid phase and combinatorial library syntheses of fused... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Solid phase and combinatorial library syntheses of fused..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Solid phase and combinatorial library syntheses of fused... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2904525